Target intelligence / Profile preview

V-type proton ATPase subunit d2 (ATP6V0D2)

Target
ATP6V0D2
Molecular classification
Enzyme (ATPase), Transporter (proton pump)
01

Overview

V-type proton ATPase subunit d2 (ATP6V0D2) is a protein component of the V0 sector of vacuolar H+-ATPases (V-ATPases), multi-subunit enzymes responsible for acidifying intracellular organelles and, in some cells, the extracellular environment. This subunit is involved in proton transport driven by ATP hydrolysis, which is crucial for processes such as endocytosis, protein degradation, and bone resorption. ATP6V0D2 is highly expressed in osteoclasts and regulates bone formation and remodeling, as well as being implicated in cancer cell survival and progression. Dysfunction or altered expression of ATP6V0D2 has been associated with diseases such as cancer and distal renal tubular acidosis, making it a potential therapeutic target in oncology and bone diseases[1][2][5].

Other names
ATPase H+ transporting V0 subunit d2V-ATPase subunit d2FLJ38708VMA6ATP6D2Vacuolar proton pump subunit d2Lysosomal 38 kDa V0 subunit d2VA0D2
02

Mechanism of action

Inhibition of proton translocation (prevents acidification of organelles or extracellular environment, induces apoptosis or impairs cancer cell survival, inhibits osteoclast-mediated bone resorption)

03

Biological functions

Intracellular acidificationMaintenance of organelle pHVacuolar transportRegulation of osteoclast fusion and bone formationExtracellular acidification (notably in bone resorption)
04

Disease associations

Cancer (colorectal cancer, esophageal cancer)Distal renal tubular acidosisDisorders of bone remodeling
05

Safety considerations

On-target toxicity (due to critical role of V-ATPases in pH maintenance in all cells)Risk of renal tubular acidosis, bone abnormalities, and general disruption of cellular homeostasis with systemic inhibitionLimited selectivity (systemic inhibition affects many tissues and cell types)
06

Interacting drugs

Bafilomycin A1 (experimental/research tool, V-ATPase inhibitor)

2 more in the full profile.

07

Biomarkers

Expression level of ATP6V0D2 (potential biomarker for certain cancers or disorders of osteoclast activity; research context)

Beyond the preview

Go deeper on V-type proton ATPase subunit d2 (ATP6V0D2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on V-type proton ATPase subunit d2 (ATP6V0D2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call